Polymerase Chain Reaction (PCR) with capillary electrophoresis
B cell lymphoproliferative disorders are frequently associated with clonal rearrangements of the immunoglobulin heavy chain (IGH) and/or immunoglobulin kappa light chain (IGK) loci. Evaluation of the IGH locus may occasionally demonstrate clonal rearrangements not detected by IGK testing, and vice versa. This test employs multiplexed PCR primers to detect gene rearrangements involving the variable segments (frameworks regions 1, 2 and 3) and joining segments of the IGH locus as well as the variable, intragenic, joining and kappa deleting element regions of the IGK locus. In conjunction with clinical, morphologic and immunophenotypic data, the detection of these clonal rearrangements may be useful in the distinction of a lymphoproliferative disorder from a non-neoplastic process. In addition, the comparison of rearrangements detected within lymphocytic infiltrates from separate samples may be useful in determining their clonal relationship. The clinical implications of gene rearrangement results must always be interpreted in the context of the individual patient’s clinicopathologic presentation.
Interpretive report provided.
*Reference ranges may change over time. Please refer to the original patient report when evaluating results.
A negative result does not exclude a B cell neoplasm. This assay is sensitive to a level of approximately 15% clonal lymphocytes and is expected to detect 90 - 95% of all B cell gene rearrangements. Factors such as uncommon rearrangements and somatic hypermutation may also result in false negative results. In addition, a positive result is not synonymous with neoplasia or specific to neoplasms of B cell origin. Clinicopathologic correlation with gene rearrangement results is required. Insufficient cellular content may result in an inadequate result.
3 - 10 days
- B-Cell Clonality
- IGH and IGK Gene Rearrangement
- B Cell Gene Rearrangement
- Gene Rearrangement, B-Cell
- Gene Rearrangement, B Cell
Collect blood or bone marrow in a lavender top tube. Refrigerate and send intact blood or bone marrow specimen within 48 hours of collection. Fresh tissue (preferably 0.5cm3, sent in RPMI) and fresh aspirates or body fluids are acceptable. Refrigerate and send, preferably within 24 hours. Frozen tissue specimens – preferably frozen with 1 hour of collection – may also be sent frozen on dry ice. Fresh cell suspensions in RPMI should be refrigerated and sent, preferably within 48 hours. Frozen cell suspensions – preferably frozen with 1 hour of collection – may also be sent frozen on dry ice. For formalin-fixed, paraffin-embedded tissue, a tissue block is preferred. Unstained, UNBAKED slides (5-8, 10-micron slides; 10-15 if few neoplastic cells are present) with associated H&E stained slide are also acceptable. Decalcified tissue or other fixatives will be accepted and the assay attempted, however these may result in failed testing due to degraded nucleic acid. Both blocks and slides should be stored at room temperature.
Extracted DNA is also acceptable if extracted in a CLIA certified laboratory.
By ordering this test the clinician acknowledges that informed consent has been obtained from the patient as required by applicable state or federal laws and the ordering clinician has authorization from the patient permitting MLabs to report the test results to the ordering clinician. Test includes pathologist interpretation of results billed as a separate additional charge. This test is not available without interpretation.